» Articles » PMID: 24203809

Femtosecond Laser-assisted Keyhole Endokeratophakia: Correction of Hyperopia by Implantation of an Allogeneic Lenticule Obtained by SMILE from a Myopic Donor

Overview
Journal J Refract Surg
Date 2013 Nov 9
PMID 24203809
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe endokeratophakia in which a small incision lenticule extraction (SMILE) lenticule from a myopic patient is implanted into a recipient eye through a small incision to correct hyperopia.

Methods: A 23-year-old aphakic woman presented following cataract surgery to remove a childhood congenital cataract with hyperopia of +12.00 -1.50 × 155, corrected distance visual acuity of counting fingers, and exotropia. A SMILE procedure using the VisuMax femto-second laser (Carl Zeiss Meditec, Jena, Germany) was performed on a donor patient with high myopia and the extracted lenticule was stored (power -10.50 diopter sphere, optical zone 5.75 mm, central lenticule thickness 127 μm). In the recipient eye, a pocket lamellar incision was created using the VisuMax SMILE software. The upper interface was separated and the donor lenticule was inserted through the small incision.

Results: One year postoperatively, retinoscopy refraction was +7.50 -3.00 × 150, a spherical equivalent refraction reduction of 5.25 diopters. Mean keratometric power increased by 2.91 diopters. The posterior surface elevation changed significantly with a central bulge into the anterior chamber. Central corneal thickness by Pentacam (Oculus Optikgeräte, Wetzlar, Germany) increased by 121 μm. Central lenticule thickness was 130 μm and central epithelial thickness was 43 μm measured by RTVue OCT (Optovue Inc., Fremont, CA). The cornea remained clear over the 1-year postoperative period.

Conclusions: Endokeratophakia appears to be a viable procedure for correcting hyperopia on the cornea by implantation of an extracted myopic SMILE lenticule from a donor patient. However, posterior surface changes and epithelial remodeling resulted in only 50% of the intended correction. No adverse side effects were observed following implantation of donor tissue for 1 year.

Citing Articles

Biochemical components of corneal stroma: a study on myopia classification based on Raman spectroscopy and deep learning methods.

Yu Z, Li Y, Xing T, Han M, Zhang Y, Gao J Biomed Opt Express. 2025; 16(1):28-41.

PMID: 39816144 PMC: 11729285. DOI: 10.1364/BOE.539721.


Long-term results of allogenic corneal lenticule of hyperopic SMILE for post-LASIK ectasia.

Li M, Wei R, Qin B, Chang J, Zhou X iScience. 2024; 27(9):110689.

PMID: 39280629 PMC: 11399612. DOI: 10.1016/j.isci.2024.110689.


Banking of post-SMILE stromal lenticules for additive keratoplasty: A new challenge for eye banks?.

Bievel-Radulescu R, Ferrari S, Piaia M, Mandatori D, Pandolfi A, Nubile M Int Ophthalmol. 2024; 44(1):355.

PMID: 39182212 PMC: 11345333. DOI: 10.1007/s10792-024-03283-7.


Ex Vivo Lenticule Customization for Stromal Lenticule Addition Keratoplasty.

Nubile M, Alio Del Barrio J, Cerino L, Salgari N, El Zarif M, Totta M Invest Ophthalmol Vis Sci. 2024; 65(10):9.

PMID: 39102261 PMC: 11309033. DOI: 10.1167/iovs.65.10.9.


Lamellar surgeries with SMILE-derived lenticules.

Ganesh S, Brar S, Chopra R Taiwan J Ophthalmol. 2024; 14(1):70-77.

PMID: 38654992 PMC: 11034677. DOI: 10.4103/tjo.TJO-D-23-00171.